GlassScriptPhysician profile
Dean A Floyd
NPI 1386605285
$2,397.88
in general payments reported to CMS, 2019-2025
16 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $251 · 2021: $322 · 2022: $506 · 2023: $350 · 2024: $291 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008 · Entertainment: $14.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.90 |
| Entertainment | $14.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $534.34 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $466.73 | 2019-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $331.02 | 2019-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $243.28 | 2019-2022 | |
| Abbvie INC. | $239.52 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $162.59 | 2019-2023 | Farxiga |
| Dexcom, INC. | $93.12 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $84.43 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $76.83 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $40.94 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $28.40 | 2020-2021 | |
| Glaxosmithkline, LLC. | $26.48 | 2020-2021 | |
| Gilead Sciences, INC. | $25.42 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.47 | 2022 | |
| Optos, INC. | $14.20 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $14.11 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.